Stopped Abbott has decided to discontinue our percutaneous heart pump (PHP) program and the SHIELD II trial because the product was not meeting the needs of the patients it was intended to serve.
Conditions
Coronary Artery Disease
Interventions
DEVICE: HeartMate PHP
DEVICE: Any Abiomed Impella® device approved for use in high-risk PCI